How fortunate we are to have one of the top Cancer specialists in the world helping to place our precious donor funds in the most promising areas of Breast Cancer Research. Most recently Dr. Von Hoff, as a featured speaker at the Denver conference of the American Association for Cancer Research, presented the results of …
I have written quite a bit on the subject of Molecular Profiling only to find out that the glossary of terms around this subject are many and varied. Having now spent several hours researching this subject at the National Cancer Institute perhaps their label of Molecular Diagnostics is most common. To that end take a …
Fact – The National Cancer Institue 2007 Report on Trends in Cancer made no mention of Molecular Profiling, in spite of its most recent significant contributions to the field of diagnosis and treatment therapies. I would welcome an explanation from NCI or any practicing professional in cancer research.
New Study of Targeted Therapies for Breast Cancer Establishes Model for Global Clinical Trials Two targeted medications designed to treat an aggressive form of breast cancer are being tested in a new study involving 8,000 participants in 50 countries across six continents — a clinical trial that investigators hope will provide a new model for …
This study is currently recruiting participants. Verified by Scottsdale Healthcare, September 2007 Sponsors and Collaborators: Scottsdale Healthcare Translational Genomics Research Institute (TGen) Information provided by: Scottsdale Healthcare ClinicalTrials.gov Identifier: NCT00530192 Purpose This is an open-label, multicenter pilot study in patients with advanced solid tumors. The primary objective of this study is to compare progression-free survival …
Side-Out is a proud member of the
© The Side-Out Foundation is a 501(c)(3) non-profit organization. EIN 20-2510044
Dig Pink® is a registered trademark of the Side-Out Foundation
